Delivery Order SPE2DB22D3501-SPE2DB26FTH23
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Synvisc-One syringes (6mL) with a ceiling value of $3,885.12 under a firm fixed-price contract type. The contract is non-set-aside and competitively awarded, with an ultimate completion date of July 22, 2025. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,479.42 to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a joint care injection medication. This firm fixed-price contract, awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive delivery order executed under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 6, 2025, for the supply of Synvisc-One Syringe 6ML, a hyaluronic acid injection used for osteoarthritis treatment. This firm fixed price delivery order, valued at $5,019.40, represents a competitive award with no set-aside designation and is scheduled for completion by August 7, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Synvisc-One syringes (6mL, 1 unit). This is a firm fixed price delivery order with a ceiling value of $6,009.24 and an ultimate completion date of July 2, 2025. The contract represents a non-competitive award utilizing AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The Defense Department's Medical Supply Chain awarded a $36,499.81 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Synvisc-One syringes (6mL, 1 unit). This competitively awarded, firm fixed-price contract is scheduled for completion by October 22, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026....
- This federal contract award to AmerisourceBergen Drug Corp (a major pharmaceutical distributor) is a delivery order valued at $1,251.76 for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of August 30, 2024 and is a firm-fixed price arrangement. AmerisourceBergen holds a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for...
- The Defense Logistics Agency awarded a delivery order valued at $1,942.56 to AmerisourceBergen Drug Corp for SYNVISC-One Syringes (6mL) on June 5, 2025, with completion scheduled for June 6, 2025. This non-set-aside, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $30,813.16 to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a pharmaceutical product for joint pain management. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by June 2, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $4,541.76 firm-fixed-price contract is for the supply of SYNVISC-ONE SYRINGE 6ML, a pharmaceutical product. The contract has an ultimate completion date of September 9, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Synvisc-One Syringe 6ML, a pharmaceutical product used in joint pain management. This is a firm fixed price delivery order with a ceiling value of $17,220.22 and an ultimate completion date of September 17, 2025, with performance to be executed at the contractor's Conshohocken, Pennsylvania location. The award carries no set-aside designation, indicating it was...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTH23Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,611.11 by the Defense Logistics Agency on October 29, 2025, for the supply of Synvisc-One Syringe 6ML. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 30, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. The Defense Logistics Agency, which manages the medical supply chain for the Department of Defense, utilizes its prime vendor contracts to efficiently procure medications, medical devices, and related healthcare commodities for military and veteran healthcare systems. This delivery order for Synvisc-One, an intra-articular injection used in orthopedic treatment, is consistent with AmerisourceBergen's established role as a critical vendor for federal medical procurement. The company's continued selection for such orders reflects its competitive capability to meet federal requirements, as evidenced by its portfolio of competitively awarded contracts across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 10/29/25 |